We serve Chemical Name:UNII:513S964LJO CAS:1982-49-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:UNII:513S964LJO
CAS.NO:1982-49-6
Synonyms:N-(2-methylcyclohexyl)-N’-phenylurea;1-(2-Methylcyclohexyl)-3-phenylurea;N-(2-methyl-cyclohexyl)-N’-phenyl-urea;Du Pont herbicide 1,318;Urea, N-(2-methylcyclohexyl)-N’-phenyl-;MFCD00072453;1-(2-methyl-cyclohexyl)-3-phenylurea;Trey;Urea,1-(2-methylcyclohexyl)-3-phenyl;SIDURON;Du Pont 1318;Tupersan;Urea,N-(2-methylcyclohexyl)-N’-phenyl;UNII:513S964LJO;1-phenyl-3-(2-methylcyclohexyl)-urea
Molecular Formula:C14H20N2O
Molecular Weight:232.321
HS Code:2924299034
Physical and Chemical Properties:
Melting point:N/A
Boiling point:341.4±15.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.552
PSA:41.13000
Exact Mass:232.157562
LogP:3.66
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like N-(2-methylcyclohexyl)-N’-phenylurea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-phenyl-3-(2-methylcyclohexyl)-urea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-methyl-cyclohexyl)-3-phenylurea Use and application,Urea, N-(2-methylcyclohexyl)-N’-phenyl- technical grade,usp/ep/jp grade.
Related News: Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. UNII:513S964LJO manufacturer A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan. UNII:513S964LJO supplier Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. UNII:513S964LJO vendor Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. UNII:513S964LJO factory A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan.
